{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T17:56:26Z","timestamp":1774115786527,"version":"3.50.1"},"reference-count":71,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.6457-25","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T22:26:45Z","timestamp":1766615205000},"source":"Crossref","is-referenced-by-count":1,"title":["Targeting Gut Microbiota in the Management of Functional Constipation: A Narrative Review"],"prefix":"10.2169","author":[{"given":"Tsutomu","family":"Takeda","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Juntendo University Faculty of Medicine, Japan"},{"name":"Department of Gastroenterology, Juntendo Tokyo Koto Geriatric Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Hojo","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Juntendo University Faculty of Medicine, Japan"},{"name":"Department of Gastroenterology, Juntendo Tokyo Koto Geriatric Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Asaoka","sequence":"additional","affiliation":[{"name":"Department of Pathophysiological Research and Therapeutics Gastrointestinal Diseases, Juntendo University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihito","family":"Nagahara","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Juntendo University Faculty of Medicine, Japan"},{"name":"Department of Gastroenterology, Juntendo Tokyo Koto Geriatric Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Suares NC, Ford AC. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am J Gastroenterol 106 (9): 1582-1591; quiz 1, 92, 2011.","DOI":"10.1038\/ajg.2011.164"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Drossman DA, Hasler WL. Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology 150 (6): 1257-1261, 2016.","DOI":"10.1053\/j.gastro.2016.03.035"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Zhao Y, Yu YB. Intestinal microbiota and chronic constipation. Springerplus 5 (1): 1130, 2016.","DOI":"10.1186\/s40064-016-2821-1"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Pan R, Wang L, Xu X, et al. Crosstalk between the Gut Microbiome and Colonic Motility in Chronic Constipation: Potential Mechanisms and Microbiota Modulation. Nutrients 14 (18): 2022.","DOI":"10.3390\/nu14183704"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ohkusa T, Koido S, Nishikawa Y, Sato N. Gut Microbiota and Chronic Constipation: A Review and Update. Front Med (Lausanne) 6: 19, 2019.","DOI":"10.3389\/fmed.2019.00019"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hill C, Guarner F, Reid G, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11 (8): 506-514, 2014.","DOI":"10.1038\/nrgastro.2014.66"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Dimidi E, Christodoulides S, Fragkos KC, Scott SM, Whelan K. The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr 100 (4): 1075-1084, 2014.","DOI":"10.3945\/ajcn.114.089151"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Mayer EA, Tillisch K, Gupta A. Gut\/brain axis and the microbiota. J Clin Invest 125 (3): 926-938, 2015.","DOI":"10.1172\/JCI76304"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Zoppi G, Cinquetti M, Luciano A, Benini A, Muner A, Bertazzoni Minelli E. The intestinal ecosystem in chronic functional constipation. Acta Paediatr 87 (8): 836-841, 1998.","DOI":"10.1080\/080352598750013590"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Khalif IL, Quigley EM, Konovitch EA, Maximova ID. Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation. Dig Liver Dis 37 (11): 838-849, 2005.","DOI":"10.1016\/j.dld.2005.06.008"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Zhu L, Liu W, Alkhouri R, et al. Structural changes in the gut microbiome of constipated patients. Physiol Genomics 46 (18): 679-686, 2014.","DOI":"10.1152\/physiolgenomics.00082.2014"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kim SE, Choi SC, Park KS, et al. Change of Fecal Flora and Effectiveness of the Short-term VSL#3 Probiotic Treatment in Patients With Functional Constipation. J Neurogastroenterol Motil 21 (1): 111-120, 2015.","DOI":"10.5056\/jnm14048"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Parthasarathy G, Chen J, Chen X, et al. Relationship Between Microbiota of the Colonic Mucosa vs Feces and Symptoms, Colonic Transit, and Methane Production in Female Patients With Chronic Constipation. Gastroenterology 150 (2): 367-379.e1, 2016.","DOI":"10.1053\/j.gastro.2015.10.005"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Vandeputte D, Falony G, Vieira-Silva S, Tito RY, Joossens M, Raes J. Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut 65 (1): 57-62, 2016.","DOI":"10.1136\/gutjnl-2015-309618"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Guo M, Yao J, Yang F, et al. The composition of intestinal microbiota and its association with functional constipation of the elderly patients. Future Microbiol 15: 163-175, 2020.","DOI":"10.2217\/fmb-2019-0283"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Sugitani Y, Inoue R, Inatomi O, et al. Mucosa-associated gut microbiome in Japanese patients with functional constipation. J Clin Biochem Nutr 68 (2): 187-192, 2021.","DOI":"10.3164\/jcbn.20-93"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Odamaki T, Kato K, Sugahara H, et al. Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study. BMC Microbiol 16: 90, 2016.","DOI":"10.1186\/s12866-016-0708-5"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Park J, Kato K, Murakami H, et al. Comprehensive analysis of gut microbiota of a healthy population and covariates affecting microbial variation in two large Japanese cohorts. BMC Microbiol 21 (1): 151, 2021.","DOI":"10.1186\/s12866-021-02215-0"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Oki K, Toyama M, Banno T, Chonan O, Benno Y, Watanabe K. Comprehensive analysis of the fecal microbiota of healthy Japanese adults reveals a new bacterial lineage associated with a phenotype characterized by a high frequency of bowel movements and a lean body type. BMC Microbiol 16 (1): 284, 2016.","DOI":"10.1186\/s12866-016-0898-x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Takagi T, Naito Y, Inoue R, et al. Differences in gut microbiota associated with age, sex, and stool consistency in healthy Japanese subjects. J Gastroenterol 54 (1): 53-63, 2019.","DOI":"10.1007\/s00535-018-1488-5"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Tanabe A, Adachi K, Yamaguchi Y, et al. Gut Environment and Dietary Habits in Healthy Japanese Adults and their Association with Bowel Movement. Digestion 101 (6): 706-716, 2020.","DOI":"10.1159\/000501961"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Shima T, Amamoto R, Kaga C, et al. Association of life habits and fermented milk intake with stool frequency, defecatory symptoms and intestinal microbiota in healthy Japanese adults. Benef Microbes 10 (8): 841-854, 2019.","DOI":"10.3920\/BM2019.0057"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Cherbut C, Ferrier L, Roz\u00e9 C, et al. Short-chain fatty acids modify colonic motility through nerves and polypeptide YY release in the rat. Am J Physiol 275 (6): G1415-G1422, 1998.","DOI":"10.1152\/ajpgi.1998.275.6.G1415"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Fukumoto S, Tatewaki M, Yamada T, et al. Short-chain fatty acids stimulate colonic transit via intraluminal 5-HT release in rats. Am J Physiol Regul Integr Comp Physiol 284 (5): R1269-R1276, 2003.","DOI":"10.1152\/ajpregu.00442.2002"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Bunnett NW. Neuro-humoral signalling by bile acids and the TGR5 receptor in the gastrointestinal tract. J Physiol 592 (14): 2943-2950, 2014.","DOI":"10.1113\/jphysiol.2014.271155"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Fan Y, Xu C, Xie L, et al. Abnormal bile acid metabolism is an important feature of gut microbiota and fecal metabolites in patients with slow transit constipation. Front Cell Infect Microbiol 12: 956528, 2022.","DOI":"10.3389\/fcimb.2022.956528"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Sahakian AB, Jee SR, Pimentel M. Methane and the gastrointestinal tract. Dig Dis Sci 55 (8): 2135-2143, 2010.","DOI":"10.1007\/s10620-009-1012-0"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Lee KM, Paik CN, Chung WC, Yang JM, Choi MG. Breath methane positivity is more common and higher in patients with objectively proven delayed transit constipation. Eur J Gastroenterol Hepatol 25 (6): 726-732, 2013.","DOI":"10.1097\/MEG.0b013e32835eb916"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Attaluri A, Jackson M, Valestin J, Rao SS. Methanogenic flora is associated with altered colonic transit but not stool characteristics in constipation without IBS. Am J Gastroenterol 105 (6): 1407-1411, 2010.","DOI":"10.1038\/ajg.2009.655"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. O&apos;Callaghan A, van Sinderen D. Bifidobacteria and Their Role as Members of the Human Gut Microbiota. Front Microbiol 7: 925, 2016.","DOI":"10.3389\/fmicb.2016.00925"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Rivi\u00e8re A, Selak M, Lantin D, Leroy F, De Vuyst L. Bifidobacteria and Butyrate-Producing Colon Bacteria: Importance and Strategies for Their Stimulation in the Human Gut. Front Microbiol 7: 979, 2016.","DOI":"10.3389\/fmicb.2016.00979"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Reichardt N, Duncan SH, Young P, et al. Phylogenetic distribution of three pathways for propionate production within the human gut microbiota. Isme j 8 (6): 1323-1335, 2014.","DOI":"10.1038\/ismej.2014.14"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol 19 (1): 29-41, 2017.","DOI":"10.1111\/1462-2920.13589"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Nishijima S, Suda W, Oshima K, et al. The gut microbiome of healthy Japanese and its microbial and functional uniqueness. DNA Res 23 (2): 125-133, 2016.","DOI":"10.1093\/dnares\/dsw002"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Ihara E, Manabe N, Ohkubo H, et al. Evidence-Based Clinical Guidelines for Chronic Constipation 2023. Digestion 106 (1): 62-89, 2025.","DOI":"10.1159\/000540912"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Ojetti V, Ianiro G, Tortora A, et al. The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial. J Gastrointestin Liver Dis 23 (4): 387-391, 2014.","DOI":"10.15403\/jgld.2014.1121.234.elr"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Yeun Y, Lee J. Effect of a double-coated probiotic formulation on functional constipation in the elderly: a randomized, double blind, controlled study. Arch Pharm Res 38 (7): 1345-1350, 2015.","DOI":"10.1007\/s12272-014-0522-2"},{"key":"38","doi-asserted-by":"publisher","unstructured":"38. Ibarra A, Latreille-Barbier M, Donazzolo Y, Pelletier X, Ouwehand AC. Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, and dose-ranging trial. Gut Microbes 9 (3): 236-251, 2018.","DOI":"10.1080\/19490976.2017.1412908"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Airaksinen K, Yeung N, Lyra A, et al. The effect of a probiotic blend on gastrointestinal symptoms in constipated patients: a double blind, randomised, placebo controlled 2-week trial. Benef Microbes 10 (6): 617-627, 2019.","DOI":"10.3920\/BM2018.0163"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Dimidi E, Zdanaviciene A, Christodoulides S, et al. Randomised clinical trial: Bifidobacterium lactis NCC2818 probiotic vs placebo, and impact on gut transit time, symptoms, and gut microbiology in chronic constipation. Aliment Pharmacol Ther 49 (3): 251-264, 2019.","DOI":"10.1111\/apt.15073"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Kommers MJ, Silva Rodrigues RA, Miyajima F, et al. Effects of Probiotic Use on Quality of Life and Physical Activity in Constipated Female University Students: A Randomized, Double-Blind Placebo-Controlled Study. J Altern Complement Med 25 (12): 1163-1171, 2019.","DOI":"10.1089\/acm.2019.0134"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Martoni CJ, Evans M, Chow CT, Chan LS, Leyer G. Impact of a probiotic product on bowel habits and microbial profile in participants with functional constipation: A randomized controlled trial. J Dig Dis 20 (9): 435-446, 2019.","DOI":"10.1111\/1751-2980.12797"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Madempudi RS, Neelamraju J, Ahire JJ, Gupta SK, Shukla VK. Bacillus coagulans Unique IS2 in Constipation: A Double-Blind, Placebo-Controlled Study. Probiotics Antimicrob Proteins 12 (2): 335-342, 2020.","DOI":"10.1007\/s12602-019-09542-9"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Ghafar MYA, Yaakup H, Ali RAR, Shah SA. Evaluation of the Efficacy of Probiotics (MCP<sup>\u00ae<\/sup> BCMC<sup>\u00ae<\/sup> Strains) Treating Constipation in Elderly Patients with Multiple Chronic Co-Morbidities: A Randomized Control Trial. J Nutr Health Aging 24 (10): 1066-1072, 2020.","DOI":"10.1007\/s12603-020-1494-1"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Ara\u00fajo AM, Botelho PB, Ribeiro DJS, Magalh\u00e3es KG, Nakano EY, Arruda SF. A multiple-strain probiotic product provides a better enzymatic antioxidant response in individuals with constipation in a double-blind randomized controlled trial. Nutrition 89: 111225, 2021.","DOI":"10.1016\/j.nut.2021.111225"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Wang L, Wang L, Tian P, et al. A randomised, double-blind, placebo-controlled trial of Bifidobacterium bifidum CCFM16 for manipulation of the gut microbiota and relief from chronic constipation. Food Funct 13 (3): 1628-1640, 2022.","DOI":"10.1039\/D1FO03896F"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Takeda T, Asaoka D, Nojiri S, et al. Usefulness of Bifidobacterium longum BB536 in Elderly Individuals With Chronic Constipation: A Randomized Controlled Trial. Am J Gastroenterol 118 (3): 561-568, 2023.","DOI":"10.14309\/ajg.0000000000002028"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Wu Y, Bai Z, Jin Y, et al. A randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of Weizmannia coagulans BC99 in the treatment of chronic constipation in adults. Front Nutr 11: 1395083, 2024.","DOI":"10.3389\/fnut.2024.1395083"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Salo E, Roche D, Gomez-Martinez VB, et al. Bifidobacterium animalis subsp. lactis BLa80 regulates the intestinal habit in adults with chronic constipation: a multicentre, randomised, double-blind, placebo-controlled study. Benef Microbes 15 (6): 679-688, 2024.","DOI":"10.1163\/18762891-bja00038"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Zhang X, Jia Y, Li X, et al. Effects of complex probiotics on intestinal function and its regulatory mechanism in patients with constipation. Benef Microbes 16 (1): 35-49, 2024.","DOI":"10.1163\/18762891-bja00039"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Roos S, Dahlgren AL, Mao YK, et al. Therapeutic Value of Lactobacillus gasseri 345A in Chronic Constipation. Neurogastroenterol Motil 37 (5): e70012, 2025.","DOI":"10.1111\/nmo.70012"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Ford AC, Quigley EM, Lacy BE, et al. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol 109 (10): 1547-1561; quiz 6, 62, 2014.","DOI":"10.1038\/ajg.2014.202"},{"key":"53","unstructured":"53. Chmielewska A, Szajewska H. Systematic review of randomised controlled trials: probiotics for functional constipation. World J Gastroenterol 16 (1): 69-75, 2010."},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Miller LE, Ouwehand AC. Probiotic supplementation decreases intestinal transit time: meta-analysis of randomized controlled trials. World J Gastroenterol 19 (29): 4718-4725, 2013.","DOI":"10.3748\/wjg.v19.i29.4718"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. van der Schoot A, Helander C, Whelan K, Dimidi E. Probiotics and synbiotics in chronic constipation in adults: A systematic review and meta-analysis of randomized controlled trials. Clin Nutr 41 (12): 2759-2777, 2022.","DOI":"10.1016\/j.clnu.2022.10.015"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Mart\u00ednez-Mart\u00ednez MI, Calabuig-Tols\u00e1 R, Cauli O. The effect of probiotics as a treatment for constipation in elderly people: A systematic review. Arch Gerontol Geriatr 71: 142-149, 2017.","DOI":"10.1016\/j.archger.2017.04.004"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Deng X, Shang X, Zhou L, et al. Efficacy and Safety of Probiotics in Geriatric Patients with Constipation: Systematic Review and Meta-Analysis. J Nutr Health Aging 27 (11): 1140-1146, 2023.","DOI":"10.1007\/s12603-023-2028-4"},{"key":"58","doi-asserted-by":"publisher","unstructured":"58. Yaeshima T, Takahashi S, Matsumoto N, Ishibashi N, Hayasawa H, Iino H. Effect of Yogurt Containing Bifidobacterium longum BB536 on the Intestinal Environment, Fecal Characteristics and Defecation Frequency. Bioscience and Microflora 16 (2): 73-77, 1997.","DOI":"10.12938\/bifidus1996.16.73"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Agachan F, Chen T, Pfeifer J, Reissman P, Wexner SD. A constipation scoring system to simplify evaluation and management of constipated patients. Dis Colon Rectum 39 (6): 681-685, 1996.","DOI":"10.1007\/BF02056950"},{"key":"60","doi-asserted-by":"publisher","unstructured":"60. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 130 (5): 1480-1491, 2006.","DOI":"10.1053\/j.gastro.2005.11.061"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Kusano M, Shimoyama Y, Sugimoto S, et al. Development and evaluation of FSSG: frequency scale for the symptoms of GERD. J Gastroenterol 39 (9): 888-891, 2004.","DOI":"10.1007\/s00535-004-1417-7"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Kakuta E, Yamashita N, Katsube T, et al. Abdominal symptom-related QOL in individuals visiting an outpatient clinic and those attending an annual health check. Intern Med 50 (15): 1517-1522, 2011.","DOI":"10.2169\/internalmedicine.50.5390"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Odamaki T, Kato K, Sugahara H, Xiao JZ, Abe F, Benno Y. Effect of probiotic yoghurt on animal-based diet-induced change in gut microbiota: an open, randomised, parallel-group study. Benef Microbes 7 (4): 473-484, 2016.","DOI":"10.3920\/BM2015.0173"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. Sugahara H, Odamaki T, Fukuda S, et al. Probiotic Bifidobacterium longum alters gut luminal metabolism through modification of the gut microbial community. Sci Rep 5: 13548, 2015.","DOI":"10.1038\/srep13548"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Odamaki T, Sugahara H, Yonezawa S, et al. Effect of the oral intake of yogurt containing Bifidobacterium longum BB536 on the cell numbers of enterotoxigenic Bacteroides fragilis in microbiota. Anaerobe 18 (1): 14-18, 2012.","DOI":"10.1016\/j.anaerobe.2011.11.004"},{"key":"66","doi-asserted-by":"publisher","unstructured":"66. Fukuda S, Toh H, Hase K, et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469 (7331): 543-547, 2011.","DOI":"10.1038\/nature09646"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. Tian Y, Zuo L, Guo Q, et al. Potential role of fecal microbiota in patients with constipation. Therap Adv Gastroenterol 13: 1756284820968423, 2020.","DOI":"10.1177\/1756284820968423"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Ding C, Fan W, Gu L, et al. Outcomes and prognostic factors of fecal microbiota transplantation in patients with slow transit constipation: results from a prospective study with long-term follow-up. Gastroenterol Rep (Oxf) 6 (2): 101-107, 2018.","DOI":"10.1093\/gastro\/gox036"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69. Wu L, Yuan Q, Wu L, et al. Efficacy of washed microbiota transplantation for therapeutic targets of refractory functional constipation and the influencing factors: a single-center, retrospective, 24-week follow-up study. BMC Gastroenterol 23 (1): 291, 2023.","DOI":"10.1186\/s12876-023-02929-7"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70. Tian H, Ge X, Nie Y, et al. Fecal microbiota transplantation in patients with slow-transit constipation: A randomized, clinical trial. PLoS One 12 (2): e0171308, 2017.","DOI":"10.1371\/journal.pone.0171308"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71. Fang S, Wu S, Ji L, Fan Y, Wang X, Yang K. The combined therapy of fecal microbiota transplantation and laxatives for functional constipation in adults: A systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore) 100 (14): e25390, 2021.","DOI":"10.1097\/MD.0000000000025390"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_6457-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T03:29:24Z","timestamp":1766806164000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_6457-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":71,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6457-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"6457-25"}}